Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRG007 Combination Therapy in Advanced Colorectal Cancer
NCT07737600Phase 2Not yet recruiting
- Sponsor
- Lepu Biopharma Co., Ltd.
- Start
- Aug 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
A Phase 2 trial of MRG007 in colorectal cancer (CRC), sponsored by Lepu Biopharma Co., Ltd.. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
MRG007
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT07737600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07737600.